Xtx Topco LTD Dbv Technologies S.A. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Xtx Topco LTD holds 12,618 shares of DBVT stock, worth $10,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,618

Holding current value

$10,599

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$0.75 - $0.95 $9,463 - $11,987	12,618 New	12,618 $9,000
Q3 2023 Nov 13, 2023	BUY	$1.3 - $1.88 $18,753 - $27,120	14,426 New	14,426 $19,000

Others Institutions Holding DBVT

# of Institutions

Shares Held

37.7M

Call Options Held

Put Options Held

Baker Bros. Advisors LP New York, NY

14.6M
Shares

$12.3 Million
0.14% of portfolio
Braidwell LP Stamford, CT

7.84M
Shares

$6.59 Million
0.19% of portfolio
Yiheng Capital Management, L.P. San Francisco, CA

5.57M
Shares

$4.68 Million
0.23% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3.11M
Shares

$2.61 Million
0.01% of portfolio
Vivo Capital, LLC Palo Alto, CA

2.71M
Shares

$2.28 Million
0.27% of portfolio

View Full List

About DBV Technologies S.A.

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $158M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

More about DBVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account